Decreased glomerular proteinase activity in the streptozotocin diabetic rat

American Journal of Nephrology

Volumn 19, Issue 3, 1999, Pages 441-446

  Song, Ruo H ^b   Singh, Ashok K ^b   Leehey, David J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Collagenase; Diabetes; Extracellular matrix; Mesangium; Streptozotocin

Indexed keywords

CATHEPSIN B; COLLAGENASE; HUMAN INSULIN; PROTEINASE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GLOMERULUS; INTRAVENOUS DRUG ADMINISTRATION; MALE; MESANGIUM; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TIME;

ANIMALS; CATHEPSIN B; COLLAGENASES; DIABETES MELLITUS, EXPERIMENTAL; KIDNEY GLOMERULUS; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033001724     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013492     Document Type: Article

References (32)

1. Abrass CK, Peterson CV, Raugi GJ: Phenotypic expression of collagen types in mesangial matrix of diabetic and nondiabetic rats. Diabetes 1988;37:1695-1702.
2. Cohen MP, Klein CV: Glomerulopathy in rats with streptozotocin diabetes: Accumulation of glomerular basement membrane analogous to human diabetic nephropathy. J Exp Med 1979; 149:623-631.
3. Cohen MP, Khalifa A: Renal glomerular collagen synthesis in streptozotocin diabetes: Reversal of increased basement membrane synthesis with insulin therapy. Biochim Biophys Acta 1977;500:395-404.
4. Davies M, Martin J, Thomas GJ, Lovett DH: Proteinases and glomerular matrix turnover. Kidney Int 1992;41:671-678.
5. Kasinath BS, Singh AK, Kanwar YS, Lewis EJ: Puromycin aminonucleoside specifically reduces heparan sulfate proteoglycan core protein content of cultured glomerular epithelial cells. Am J Physiol 1988;24:F590-F596.
6. Unemori EN, Bouhana KS, Werk Z: Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells. J Biol Chem 1990;265:445-451.
7. 4. Nature (London) 1970;227:680-683.
8. Leehey DJ, Song RH, Alavi N, Singh AK: Decreased degradative enzymes in mesangial cells cultured in high glucose media. Diabetes 1995;44:929-935.
9. Wong AP, Cortez SL, Baricos WH: Role of plasmin and gelatinase in extracellular matrix degradation by cultured rat mesangial cells. Am J Physiol 1992;263:F1112-1118.
10. Achkar C, Gong Q, Frankfater A, Bajkowski AS: Differences in targeting and secretion of cathepsins B and L by BALB/3T3 fibroblasts and Moloney murine sarcoma virus-transformed BALB/3T3 fibroblasts. J Biol Chem 1990;265:13650-13654.
11. Singh AK: Proteolytic machinery of the glomerular epithelial cell against IgG. Biophys Res Commun 1992;186:639-644.
12. McConahey PJ, Dixon FJ: A method to trace iodination of proteins for in vivo studies. Int Arch Allergy Appl Immunol 1966;29:185-189.
13. Autio-Harmainen H, Hurskainen T, Niskasaari K, Hoyhtya M, Tryggvason K: Simultaneous expression of 70 kilodalton type IV collagenase and type IV collagen α (IV) chain genes by cells of early human placenta and gestational endometrium. Lab Invest 1992;67:191-200.
14. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H: ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 1992;41:1520-1527.
15. Lubec G, Leban J, Peyroux J, Sternberg M, Pollak A, Latzka U, Coradello H: Reduced collagenolytic activity of rat kidneys with streptozotocin diabetes. Nephron 1982;30:357-360.
16. Mohanam S, Bose SM: Influence of streptozotocin-and alloxan-induced diabetes in the rat on collagenase and certain lysosomal enzymes in relation to the degradation of connective tissue proteins. Diabetologia 1983;25:66-70.
17. Teschner M, Schaefer RM, Svarnas A, Heidland U, Heidland A: Decreased proteinase activity in isolated glomeruli of streptozotocin diabetic rats. Am J Nephrol 1989;9:464-469.
18. Reckelhoff JF, Tygart VL, Mitias MM, Walcott JL: STZ-induced diabetes results in decreased activity of glomerular cathepsin and metalloprotease in rats. Diabetes 1993;42:1425-1432.
19. Reckelhoff JF, Tygart VL, Racusen LC, Dzielak DJ: Glomerular metalloprotease activity in streptozotocin-treated rats and in spontaneously diabetic rats (BB/DP). Life Sci 1994;55:941-950.
20. Schaefer L, Schaefer RM, Ling H, Teschner M, Heidland A: Renal proteinases and kidney hypertrophy in experimental diabetes. Diabetologia 1994;37:567-571.
21. Nakamura T, Fukui M, Ebihara I, Osada S, Tomino V, Koide H: Abnormal gene expression of matrix metalloproteinases and their inhibitor in glomeruli from diabetic rats. Renal Physiol Biochem 1994;17:326-325.
22. Baricos WH, Cortez SL, Eldhar SS, Schnaper HW: ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/ MMP-2 cascade. Kidney Int 1995;47:1039-1047.
23. Brees DK, Narita I, Ketteler M, Noble NA, Border WA: Effect of high glucose on the expression of plasminogen activator inhibitor (PAI-1) in rat mesangial cells. J Am Soc Nephrol 1993;4:647A.
24. Tada H, Tsukamoto M, Ishii H, Igosai S: A high concentration of glucose alters the production of tPA, uPA and PAI-1 antigens from human mesangial cells. Diabetes Res Clin Pract 1994;24:33-39.
25. Border WA, Noble NA: Cytokines in kidney disease: The role of transforming growth factor-β. Am J Kidney Dis 1993;22:105-113.
26. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN: High glucose-induced proliferation of mesangial cells is reversed by autocrine TGF-β. Kidney Int 1992;42:647-656.
27. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Diabetic kidney disease is linked to elevated expression of transforming growth factor-beta. Proc Natl Acad Sci USA 1993;90:1814-1818.
28. Leehey DJ, Song RH, Alavi N, Singh AK: Decreased degradative enzymes in mesangial cells cultured in high glucose media. Diabetes 1995;44:929-935.
29. Song RH, Singh AK, Alavi N, Leehey DJ: Decreased collagenase activity of mesangial cells incubated in high glucose media is reversed by neutralizing antibody to transforming growth factor-beta. J Am Soc Nephrol 1994;4:972A.
30. Brownlee M, Vlassara H, Cerami A: Nonenzymatic glycosylation and pathogenesis of diabetic complications. Ann Intern Med 1984;101: 527-537.
31. Mitsuhashi T, Nakayama H, Itoh T, Kuwajima S, Aoki S, Atsumi T, Koike T: Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat. Diabetes 1993;42:826-832.
32. Lubec G, Pollak A: Reduced susceptibility of nonenzymatically glycosylated glomerular basement membrane to proteases: Is thickening of diabetic glomerular basement membranes due to reduced proteolytic degradation? Renal Physiol 1980;3:4-8.